PMID- 32929316
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231104
IS  - 0973-3930 (Print)
IS  - 1998-3832 (Electronic)
IS  - 1998-3832 (Linking)
VI  - 40
IP  - 3
DP  - 2020 Sep
TI  - Diagnosis and principles of management of gestational diabetes mellitus in the 
      prevailing COVID-19 pandemic.
PG  - 329-334
LID - 10.1007/s13410-020-00860-1 [doi]
AB  - BACKGROUND: Limited medical facilities are available due to Covid-19 pandemic. 
      Nevertheless, all efforts should be made in planning judicial and possible 
      methods of delivering health care, particularly to pregnant woman with GDM. GDM 
      may play a crucial role in the increasing prevalence of diabetes and obesity and 
      also may be the origin of cardiometabolic diseases. METHODS: It is mandatary to 
      diagnose and care pregnant woman with GDM. The test suggested to diagnose GDM has 
      to be evidence based and in this regard "a single test procedure" evaluated meets 
      this requirement. This doable test has been accepted by the Diabetes in Pregnancy 
      Study Group India (DIPSI) and approved by MHFW-GOI, WHO, International Diabetes 
      Federation, and International Federation of Obstetricians and Gynecologists. 
      MHFW-GOI also recommends testing at first antenatal visit and then at 24-28 weeks 
      of gestation. This opportunity can also be utilized for performing 
      ultrasonography for assessing fetal development. RESULT: The first-line 
      management is MNT and life style modifications. Non-responders may require 
      insulin or OHA. The target glycemic control is FPG ~ 5.0 mmol/dl (90 mg/dl) and 2 
      h PPPG ~ 6.7 mmol/dl (120 mg/dl). The goal is to obtain newborns birth weight 
      appropriate for gestational age between 2.5 and 3.5 kg, a step to prevent 
      offspring developing diabetes. CONCLUSION: The essential precaution required 
      during COVID pandemic is to wear face mask, avoid crowded places, and maintain 
      social distancing. Finally, the economical and evidence based "single test 
      procedure" of DIPSI is most appropriate for screening during the COVID pandemic.
CI  - (c) Research Society for Study of Diabetes in India 2020.
FAU - Seshiah, Veeraswamy
AU  - Seshiah V
AD  - Dr. Balaji Diabetes Care Center and Dr. Seshiah Diabetes Research Institute, 
      Chennai, 600029 India.
FAU - Balaji, Vijayam
AU  - Balaji V
AD  - Dr. Balaji Diabetes Care Center and Dr. Seshiah Diabetes Research Institute, 
      Chennai, 600029 India.
FAU - Banerjee, Samar
AU  - Banerjee S
AD  - Vivekananda Institute of Medical Sciences, Calcuta, India. GRID: grid.416884.7
FAU - Sahay, Rakesh
AU  - Sahay R
AD  - Department of Endocrinology, Osmania Medical College & Osmania General Hospital, 
      Hyderabad, India. GRID: grid.417029.9. ISNI: 0000 0001 2112 3753
FAU - Divakar, Hema
AU  - Divakar H
AD  - Divakar's Specialty Hospital, Bengaluru, India.
FAU - Jain, Rajesh
AU  - Jain R
AD  - Jain Hospital, Kanpur, Uttar Pradesh India.
FAU - Chawla, Rajeev
AU  - Chawla R
AD  - Diabetes in Pregnancy Study Group India, Delhi, India.
FAU - Das, Ashok Kumar
AU  - Das AK
AD  - Pondicherry Institute of Medical Sciences, Pondicherry, India. GRID: 
      grid.415098.1. ISNI: 0000 0004 1767 8424
FAU - Gupta, Sunil
AU  - Gupta S
AD  - Diabetes in Pregnancy Study Group India, Nagpur, India.
FAU - Krishnan, Dharani
AU  - Krishnan D
AD  - Chennai, India.
LA  - eng
PT  - Journal Article
DEP - 20200909
PL  - India
TA  - Int J Diabetes Dev Ctries
JT  - International journal of diabetes in developing countries
JID - 101285656
PMC - PMC7480657
OTO - NOTNLM
OT  - Fasting plasma glucose (FPG)
OT  - Gestational diabetes mellitus (GDM)
OT  - Government of India (MHFW-GOI)
OT  - Medical nutrition therapy (MNT)
OT  - Ministry of Health and Family Welfare
OT  - Oral hypoglycemic agent (OHA)
OT  - Postprandial plasma glucose(PPPG)
EDAT- 2020/09/16 06:00
MHDA- 2020/09/16 06:01
PMCR- 2020/09/09
CRDT- 2020/09/15 05:47
PHST- 2020/09/16 06:00 [pubmed]
PHST- 2020/09/16 06:01 [medline]
PHST- 2020/09/15 05:47 [entrez]
PHST- 2020/09/09 00:00 [pmc-release]
AID - 860 [pii]
AID - 10.1007/s13410-020-00860-1 [doi]
PST - ppublish
SO  - Int J Diabetes Dev Ctries. 2020 Sep;40(3):329-334. doi: 
      10.1007/s13410-020-00860-1. Epub 2020 Sep 9.